Metabolic reprogramming-driven neuroimmunoregulation: Key mechanisms and therapeutic opportunities and challenges in central nervous system disorders
- DOI
- 10.1016/j.arr.2026.103291
- Published
- 2026-10
- Container
- Ageing Research Reviews
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.arr.2026.103291,
title = {Metabolic reprogramming-driven neuroimmunoregulation: Key mechanisms and therapeutic opportunities and challenges in central nervous system disorders},
author = {Nan Li and Yuanyuan Wu and Huiyi Feng and Xuemin Jian and Zhi Yang and Xilian Wang and Xiaoan Li and Yuan Yin and Yu Long},
year = {2026},
journal = {Ageing Research Reviews},
doi = {10.1016/j.arr.2026.103291},
url = {https://doi.org/10.1016/j.arr.2026.103291}
}RIS
TY - JOUR TI - Metabolic reprogramming-driven neuroimmunoregulation: Key mechanisms and therapeutic opportunities and challenges in central nervous system disorders AU - Nan Li AU - Yuanyuan Wu AU - Huiyi Feng AU - Xuemin Jian AU - Zhi Yang AU - Xilian Wang AU - Xiaoan Li AU - Yuan Yin AU - Yu Long PY - 2026 JO - Ageing Research Reviews DO - 10.1016/j.arr.2026.103291 UR - https://doi.org/10.1016/j.arr.2026.103291 ER -
APA
Li, N., Wu, Y., Feng, H., Jian, X., Yang, Z., Wang, X., Li, X., Yin, Y., & Long, Y. (2026). Metabolic reprogramming-driven neuroimmunoregulation: Key mechanisms and therapeutic opportunities and challenges in central nervous system disorders. Ageing Research Reviews. https://doi.org/10.1016/j.arr.2026.103291
Source records
- crossref · retrieved 2026-09-25T14:57:57.498Z